ClinicalTrials.Veeva

Menu

Levosimendan Versus Milrinone in Off Pump CABG Surgery

A

Assiut University

Status and phase

Unknown
Phase 4

Conditions

Hemodynamics

Treatments

Drug: Milrinone
Drug: Levosimendan

Study type

Interventional

Funder types

Other

Identifiers

NCT03855579
Levosimendan, Milrinone, CABG

Details and patient eligibility

About

To compare the efficacy of Levosimendan versus Milrinone in supporting hemodynamics during off-pump coronary artery bypass grafting surgery in patients with low ejection fraction.

Full description

The major challenge during off-pump coronary artery bypass graft surgery is to maintain optimum hemodynamics by optimizing the intravascular volume and by using some inotropes. However, conventional inotropes such as beta-agonists are associated with tachycardia and arrhythmia which increase myocardial oxygen demand.

Levosimendan is an inodilator which exerts its positive inotropic effect by enhancing the sensitivity of troponin C to calcium without increasing intracellular calcium concentration. Levosimendan also decreases the systemic vascular resistance, so, it increases the cardiac output without increasing myocardial oxygen consumption.

This study aims to compare the efficacy of Levosimendan versus Milrinone in supporting hemodynamics during off-pump coronary artery bypass grafting surgery in patients with low ejection fraction.

Enrollment

60 estimated patients

Sex

All

Ages

30 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Elective off-pump coronary artery bypass grafting surgery.
  • ejection fraction < 50%

Exclusion criteria

  • Patients with severe renal impairment or renal failure.
  • Patients on mechanical support (intra-aortic balloon pump)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

60 participants in 2 patient groups

Levosimendan
Experimental group
Description:
Intraoperative infusion of Levosimendan
Treatment:
Drug: Levosimendan
Milrinone
Active Comparator group
Description:
Intraoperative infusion of Milrinone
Treatment:
Drug: Milrinone

Trial contacts and locations

1

Loading...

Central trial contact

Fatma Mohamed, M.D.; Hany M. Osman, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems